FilingSEC EDGAR8-K
NRX Pharmaceuticals Files Investor Presentation
· SEC accepted
StageOngoing
Filing content
The company filed an investor presentation used in meetings with investors and analysts as an exhibit to its 8-K report.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…